DOA
ABMD

D'Orazio & Associates’s Abiomed Inc ABMD Stock Holding History

D'Orazio & Associates’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-14
Closed -$4K – 383
2019
Q2 		$4K Hold
14
– – ﹤0.01% 288
2019
Q1 		$4K Buy
+14
New +$4.65K ﹤0.01% 292

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

D'Orazio & Associates's ABMD Position: Q3 2019 in Review

D'Orazio & Associates sold out of Abiomed Inc (ABMD) in Q3 2019, closing a stake of 14 shares — an estimated $4K sold.

D'Orazio & Associates first reported a position in ABMD in Q1 2019 and held it in 2 quarters. The position peaked at $4K in Q2 2019. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

  • D'Orazio & Associates reported no remaining Abiomed Inc position as of Q3 2019 after selling out during the quarter.
  • D'Orazio & Associates sold 14 Abiomed Inc shares in Q3 2019, an estimated $4K.
  • D'Orazio & Associates first reported a position in Abiomed Inc in Q1 2019 and held it in 2 quarters.
  • D'Orazio & Associates's Abiomed Inc position peaked at $4K in Q2 2019.
  • 443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on D'Orazio & Associates's 13F filing for Q3 2019, filed 1 Nov 2019.